The AI translating the ancient, alien language of proteins
Researchers in Israel have just unveiled a system that reads unknown molecular sequences and converts their functions into plain text. Biology's oldest communication barrier is falling.

Biology is a vast library written in a script we can only barely decipher. We know the alphabet—the amino acids twisting themselves into frantic, microscopic origami—but the actual meaning of those folded shapes has largely remained locked in the dark. We could look at a protein, but we could not ask it what it did.
Until this morning. Right now, researchers from Technion and Tel Aviv University are quietly tearing down the oldest language barrier on earth. They have just unveiled a new AI system that performs a trick of near-magical utility: it reads the raw, unbroken sequence of a protein and translates it directly into text.
Historically, figuring out a protein's function was an agonizing game of molecular trial and error. It took years of blind testing and crystalline observation just to deduce a single molecule's day job in the cellular machinery. You had the physical object, but no instruction manual. Now, the machine treats the biological code as a foreign dialect. It digests the sequence of an entirely unknown protein and hands back a written description of its function. The black box opens. The protein speaks.
The immediate shockwave is hitting drug discovery, and it is hitting hard. When you can fluently read the molecular script, you can begin to edit it with precision. Researchers can suddenly search the vast, uncharted wilderness of unknown proteins for specific tools, accelerating the timeline of biological understanding from decades to mere moments.
We spent the last half-century meticulously transcribing the letters of life. Today, we finally start reading the book.
Related stories

The resurrection of a 3.2-billion-year-old enzyme
Scientists have rebuilt a functional protein from the dawn of life on Earth. The breakthrough offers both a window into our origins and a structural blueprint for modern biotechnology.

Research indicates BCG tuberculosis vaccine alters brain immunity and Alzheimer's markers
New studies suggest the century-old inoculation can remodel the central nervous system's immune environment, expanding its potential applications beyond respiratory disease prevention.

McMaster University researchers develop dual-target CAR-T therapy for glioblastoma
A newly published preclinical study outlines a therapeutic approach that eliminates detectable tumors in models by attacking both cancer cells and their supporting environment.